Overview

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the therapeutic equivalence and safety of Adapalene and Benzoyl Peroxide 0.1%/2.5% Gel (Taro Pharmaceuticals Inc.) and Epiduo® (Adapalene and Benzoyl Peroxide 0.1%/2.5% Gel) (Galderma Laboratories, L.P.) in the treatment of acne vulgaris, and to demonstrate the superiority of the efficacy of the test and reference products over the vehicle (placebo) control in the treatment of acne vulgaris.

Phase:

Phase 1

Details

Lead Sponsor:

Taro Pharmaceuticals USA

Treatments:

Adapalene
Adapalene, Benzoyl Peroxide Drug Combination
Benzoyl Peroxide